ProtoKinetix, Inc.

Overview

Compare with another stock.

• TickerPKTX¹
• IndustryPharmaceutical Preparations¹
• HeadquartersDalton, Ohio¹
• Incorporated inNV²
• Business address109 W. Main St., Dalton, Oh 44618²
• Filer categoryNon-accelerated filer, Smaller reporting company²
• Legal formCorporation

See how the biggest companies compare on our leaderboards

Our capital requirements and the uncertainty of being able to obtain additional funding on terms acceptable to us;³ From its latest annual report

Corporate structure

ProtoKinetix, Inc. sits at the top of its group. 1 entity, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.

Built from major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

What it owns

What ProtoKinetix, Inc. reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Intangibles and goodwill

Properties, in its own words

The Company’s principal executive office, for all operations during the year 2025 was at 109 W. Main St, Dalton, Oh 44618.

The Company does not have a lease for its principal executive office but rents month to month. A lease on the space is held by the CFO’s, company, The Guzzetta Company LLC. The Company paid $500 per month for the office ($500 in 2024). ProtoKinetix does not own any real property.

Item 2 of the 10-K filed Sep 3, 2026.³

Leadership

Who has led ProtoKinetix, Inc., and when. Pick a name to see everywhere that person has worked.

• Chief executive officerClarence Edward Smith Mar 9, 2015 to Sep 27, 2024¹³
• Chief executive officerRoss Laurence Senior Sep 12, 2014 to Sep 12, 2014¹⁴
• PresidentKeith R. Brunt Jul 7, 2026 to now¹⁵
• PresidentClarence Edward Smith Mar 9, 2015 to Sep 27, 2024¹³
• PresidentMark L. Baum Jun 7, 2007 to Jun 7, 2007¹⁶
• Chief financial officerMichael Richard Guzzetta Dec 4, 2017 to Oct 27, 2023¹⁷
• Chief financial officerSusan Marie Woodward Oct 8, 2014 to Feb 8, 2017¹⁸

Former names

• RJV NETWORK INCNov 19, 2001 to May 24, 2004²

Timeline

1. Jun 17, 20268-K Executive or director change; Other events²⁴
2. Nov 21, 20258-K Regulation FD disclosure²⁵
3. Nov 19, 20258-K Regulation FD disclosure²⁶
4. Nov 17, 20258-K Executive or director change; Regulation FD disclosure²⁷
5. Oct 10, 20258-K Bylaws or fiscal year changed; Shareholder vote²⁸
6. Feb 1, 20238-K Other events²⁹
7. Jan 4, 20238-K Unregistered sale of shares³⁰
8. Dec 13, 20228-K Unregistered sale of shares; Executive or director change³¹
9. Mar 21, 20228-K Unregistered sale of shares; Executive or director change³²
10. Feb 14, 20228-K Change to shareholders' rights; Executive or director change; Bylaws or fiscal year changed³³
11. Dec 23, 20218-K Change to shareholders' rights; Bylaws or fiscal year changed³⁴
12. Mar 9, 2015New chief executive Clarence Edward Smith becomes CEO¹³
13. Sep 12, 2014New chief executive Ross Laurence Senior becomes CEO¹⁴

Filings

103 filings to the SEC since October 2021: 5 annual reports, 13 quarterly reports, 11 major events, 28 insider forms, 9 large holders, 27 private raises, 10 other. The latest 20:

1. Sep 3, 202610-K ANNUAL REPORT EDGAR
2. Aug 14, 2026NT 10-Q EDGAR
3. Jul 28, 20263 EDGAR
4. Jul 7, 20263 EDGAR
5. Jun 24, 20263 EDGAR
6. Jun 17, 20268-K EDGAR
7. May 15, 2026NT 10-Q EDGAR
8. Mar 31, 2026NT 10-K EDGAR
9. Dec 23, 2025D/A EDGAR
10. Nov 21, 20258-K EDGAR
11. Nov 19, 20258-K/A FORM 8-K EDGAR
12. Nov 17, 20258-K EDGAR
13. Nov 13, 202510-Q EDGAR
14. Oct 10, 20258-K EDGAR
15. Oct 2, 2025D EDGAR
16. Sep 15, 2025DEF 14A DEFINITIVE PROXY STATEMENT EDGAR
17. Sep 5, 2025PRE 14A PRELIMINARY PROXY STATEMENT EDGAR
18. Aug 13, 202510-Q EDGAR
19. Aug 12, 2025D/A EDGAR
20. May 15, 202510-Q EDGAR

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

23 open-market trades by officers, directors and large owners since October 2021: 23 buys and 0 sales. Grants, option exercises and gifts are left out.

From Forms 4 filed with the SEC.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

• Clarence Edward SmithSC 13D/A, 5 filings Mar 21, 2022 to Jun 17, 2024³⁵
• Alexandra Blake SmithSC 13G/A, 2 filings Mar 21, 2022 to Feb 15, 2023³⁶
• Lachlan Grant YoungSC 13G/A, 2 filings Mar 21, 2022 to Feb 15, 2023³⁷

Funding

Where the company's money came from, by calendar year: private offerings filed with the SEC, federal grants, loans, contracts and other assistance from USAspending.gov, and PPP loans from the SBA. Each bar links to the records below.

Private raises

Private offerings the company reported to the SEC on Form D. The amount is what the latest filing says was sold so far, charted in the year of the first sale. Covers filings since Oct 1, 2021.

1. Sep 25, 2025Raised $147,500 in a private offering of equity³⁸ Form D: $250,000 offered in all Form D
2. Jan 27, 2025Raised $172,000 in a private offering of equity³⁹ Form D: 7 investors so far Form D
3. Mar 29, 2024Raised $240,000 in a private offering of equity⁴⁰ Form D: 8 investors so far Form D
4. Dec 26, 2023Raised $135,000 in a private offering of equity⁴¹ Form D: $200,000 offered in all Form D
5. Dec 30, 2022Raised $429,000 in a private offering of equity⁴² Form D: $500,000 offered in all Form D
6. Dec 8, 2022Raised $73,000 in a private offering of equity⁴³ Form D: $250,000 offered in all Form D
7. Jul 11, 2022Raised $225,000 in a private offering of equity⁴⁴ Form D: $350,000 offered in all Form D
8. Mar 18, 2022Raised $365,000 in a private offering of equity⁴⁵ Form D: $1 million offered in all Form D
9. Dec 22, 2021Raised $263,200 in a private offering of equity⁴⁶ Form D: $480,000 offered in all Form D
10. Nov 29, 2021Raised $20,000 in a private offering of equity⁴⁷ Form D: $200,000 offered in all Form D
11. Aug 23, 2021Raised $144,000 in a private offering of equity⁴⁸ Form D: $500,000 offered in all Form D

Held by these funds

The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026. Change is in shares since the quarter before.

13F reports cover disclosed long positions in U.S. stocks only.

SEC filer profile

How ProtoKinetix, Inc. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

• Name on EDGARProtoKinetix, Inc.¹
• CIK0001128189
• Employer ID (EIN)94-3355026³
• Filer statusNon-accelerated filer not an emerging growth company; a smaller reporting company; a shell company³
• Incorporated inNevada³
• Fiscal year endsDecember 31¹
• Industry code (SIC)2834 Pharmaceutical Preparations¹
• SEC reviewing officeOffice of Life Sciences, Division of Corporation Finance¹
• Business address109 W. Main St., Dalton, OH 44618¹
• Phone330-445-4971¹
• Shares outstanding411,630,152 shares as of Sep 2, 2026³
• Public float$1.6M as of Jun 30, 2026³
• AuditorDAVIDSON & COMPANY LLP, Vancouver, Canada PCAOB ID 731; no auditor attestation of internal control over financial reporting³
• On EDGAR sinceJun 22, 2001¹
• Filings485 in all: 4 (109), 10-Q (55), 8-K (51), D (34), D/A (27), SC 13D/A (21), 10QSB (20), 10-K (19)¹
  All 36 form types

  NT 10-Q (18), 10QSB/A (17), SC 13G/A (16), UPLOAD (13), 3 (12), 4/A (11), CORRESP (8), NT 10-K (8), 10KSB/A (6), 10KSB (5), 8-K/A (5), S-8 (4), DEFA14A (3), PRE 14A (3), SC 13G (3), 10-K/A (2), DEF 14A (2), PRER14A (2), SC 13D (2), 10-Q/A (1), 10KSB40 (1), 10SB12G (1), 10SB12G/A (1), NTN 10K (1), NTN 10Q (1), PREM14C (1), RW (1), S-8 POS (1)

• Latest filingsAnnual report (10-K) Sep 3, 2026
  Quarterly report (10-Q) Nov 13, 2025
  Proxy statement (DEF 14A) Sep 15, 2025
  Latest 8-K (8-K) Jun 17, 2026

Risk factors and legal proceedings

The risks ProtoKinetix, Inc. names in Item 1A of its 10-K filed Sep 3, 2026: 1 risk under these headings, as written.³

• We are a research and product development stage company that has not yet developed or sold any products.
• Risks Related to Product Development and Regulation
• General Corporate Risk Factors

Legal proceedings

The Company and its management are not aware of any regulatory or legal proceedings or investigations pending involving the Company, any of its subsidiaries or affiliates, or any of their respective officers, directors or employees.

The opening of Item 3, Legal Proceedings.³